Table 1.
Indicator | 2011a | 2012 | 2013 | 2014 | 2015 | 2016 | |
Viral load suppression (VLS) | |||||||
|
Patients in care, n | 28,253 | 30,462 | 30,156 | 30,630 | 28,734 | 30,874 |
|
VLS, weighted average (%) | 73 | 73 | 84 | 86 | 88 | 89 |
|
Sites above 85% VLS target, n | 0 | 0 | 9 | 10 | 14 | 16 |
|
Sites at least 10% below target, n | 13 | 13 | 1 | 1 | 0 | 1 |
Linkage to care (LTC) | |||||||
|
Diagnoses, n | 1135 | 1024 | 991 | 914 | 769 | 720 |
|
LTC, weighted average (%) | 76 | 74 | 77 | 79 | 78 | 77 |
|
Eligible sites (≥10 diagnoses), n | 21 | 20 | 19 | 20 | 20 | 19 |
|
Sites above 85% LTC target, n | 2 | 1 | 2 | 4 | 4 | 4 |
|
Sites at least 10% below target, n | 11 | 10 | 7 | 8 | 6 | 12 |
aRecommendation for antiretroviral therapy for all people living with diagnosed HIV infection made in New York City in December 2011.